The table below summarizes the most recent Inspire Medical Systems insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Inspire Medical Systems insider buys are important for investors to follow.

Date	Insider	Price	Amount
10-12-2023 Insider Buy	Charisse Y. Sparks Chief Medical Officer	$153.50 CAGR »	$15,350.00 100 shares
5-7-2018 Insider Buy	Marilyn C. Nelson Director	$16.00 CAGR »	$1,000,000.00 62,500 shares
5-7-2018 Insider Buy	Dana G. Mead Jr. Director	$16.00 CAGR »	$320,000.00 20,000 shares
5-7-2018 Insider Buy	Casey M. Tansey Director and >10% Owner	$16.00 CAGR »	$3,000,000.00 187,500 shares
5-7-2018 Insider Buy	Amzak Health Investors, LLC >10% Owner	$16.00 CAGR »	$2,000,000.00 125,000 shares
5-7-2018 Insider Buy	Shawn McCormick Director	$16.00 CAGR »	$48,000.00 3,000 shares
5-7-2018 Insider Buy	ORBIMED ADVISORS LLC >10% Owner	$16.00 CAGR »	$5,000,000.00 312,500 shares
5-7-2018 Insider Buy	Chau Quang Khuong Director and >10% Owner	$16.00 CAGR »	$5,000,000.00 312,500 shares
5-7-2018 Insider Buy	Steven Jandrich Chief Comp Off & VP, Human Res	$16.00 CAGR »	$32,800.00 2,050 shares
5-15-2012 Insider Buy	William J. Ruckelshaus President and CEO	$13.49 CAGR »	$47,215.00 3,500 shares
11-23-2011 Insider Buy	Andrew Miles Snyder Director	$8.35 CAGR »	$133,583.30 15,998 shares
11-22-2011 Insider Buy	Andrew Miles Snyder Director	$8.40 CAGR »	$2,394.00 285 shares
11-21-2011 Insider Buy	Andrew Miles Snyder Director	$8.46 CAGR »	$239,557.56 28,300 shares
11-17-2011 Insider Buy	Andrew Miles Snyder Director	$8.61 CAGR »	$617,489.00 71,700 shares

Also See: Institutional Holders of INSP
Also See: SEC filings

Below we present the annualized performance delivered by Inspire Medical Systems stock since 10-12-2023 (the date of the most recent insider purchase). The performance of the investment from the time Inspire Medical Systems insider buying occurred is the ultimate test of whether insiders were right about INSP being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	10/13/2023
End date:	05/03/2024
Start price/share:	$150.47
End price/share:	$249.72
Dividends collected/share:	$0.00
Total return:	65.96%
Annualized Gain:	118.60%
Starting investment:	$10,000.00
Ending investment:	$16,596.00
Years:	0.56

Inspire Medical Systems Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Inspire Medical Systems insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding INSP

INSP — Current Quote

Quotes delayed 20 minutes

Free INSP Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

INSP — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the Inspire Medical Systems Insider Buying occurred are:

Verisk Analytics Insider Buying
International Tower Hill Mines Insider Buying
Live Oak Bancshares Insider Buying
Compass Minerals International Insider Buying
Catheter Precision Insider Buying
Verastem Insider Buying
William Penn Bancorporation Insider Buying
Viridian Therapeutics Insider Buying
Destra Multi-alternative Fund Insider Buying
Peoples Financial Services Insider Buying

Inspire Medical Systems Insider Buying

Inspire Medical Systems Insider Buying | www.HoldingsChannel.com